Reaction Details Report a problem with these data
Target
Beta-lactamase
Ligand
BDBM466965
Substrate
n/a
Meas. Tech.
Inhibition of Beta-Lactamase Enzymes
IC50
15.0±n/a nM
Citation
Comita-Prevoir, J; Durand-Reville, TF; Gauthier, L; O''Donnell, J; Romero, J; Tommasi, R; Verheijen, JC; Wu, F; Wu, X; Zhang, J Beta-lactamase inhibitor compounds US Patent US10800778 Publication Date 10/13/2020
More Info.:
Target
Name:
Beta-lactamase
Synonyms:
Beta-lactamase | OXA-48 | Synonyms=blaOXA-48 | bla
Type:
PROTEIN
Mol. Mass.:
30363.94
Organism:
Pseudomonas aeruginosa (g-Proteobacteria)
Description:
ChEMBL_103606
Residue:
265
Sequence:
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
Inhibitor
Name:
BDBM466965
Synonyms:
(2R)-{[(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl]oxy}(fluoro)ethanoic acid lithium salt | US10800778, Example 4
Type:
Small organic molecule
Emp. Form.:
C10H12FN3O5
Mol. Mass.:
273.2178
SMILES:
CC1=C[C@@H]2CN([C@@H]1C(N)=O)C(=O)N2O[C@H](F)C(O)=O |r,t:1|